| D010714 |
Phosphatidylethanolamines |
Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids. |
Cephalin,Cephalins,Ethanolamine Phosphoglyceride,Ethanolamine Phosphoglycerides,Ethanolamineglycerophospholipids,Phosphoglyceride, Ethanolamine,Phosphoglycerides, Ethanolamine |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000072137 |
Vaping |
Inhaling of vapors produced by ELECTRONIC NICOTINE DELIVERY SYSTEMS such as E-CIGARETTES. |
ECig Use,Ecigarette Use,Nicotine Vaping,THC Vaping,E-Cig Use,E-Cigarette Use,Electronic Cigarette Use,Vape,Cigarette Use, Electronic,E Cig Use,E Cigarette Use,E-Cig Uses,E-Cigarette Uses,ECig Uses,Ecigarette Uses,Electronic Cigarette Uses,Nicotine Vapings,THC Vapings,Use, E-Cig,Use, E-Cigarette,Use, ECig,Use, Ecigarette,Use, Electronic Cigarette,Uses, Ecigarette,Vapes,Vaping, Nicotine,Vaping, THC,Vapings, Nicotine,Vapings, THC |
|
| D015415 |
Biomarkers |
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. |
Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune |
|
| D055370 |
Lung Injury |
Damage to any compartment of the lung caused by physical, chemical, or biological agents which characteristically elicit inflammatory reaction. These inflammatory reactions can either be acute and dominated by NEUTROPHILS, or chronic and dominated by LYMPHOCYTES and MACROPHAGES. |
E-Cigarette Use-Associated Lung Injury,E-Cigarette or Vaping Product Use-Associated Lung Injury,EVALI,Vaping Product Use-Associated Lung Injury,Chronic Lung Injury,Lung Injuries,Pulmonary Injury,Chronic Lung Injuries,E Cigarette Use Associated Lung Injury,E Cigarette or Vaping Product Use Associated Lung Injury,EVALIs,Injuries, Lung,Injuries, Pulmonary,Injury, Lung,Injury, Pulmonary,Lung Injuries, Chronic,Lung Injury, Chronic,Pulmonary Injuries,Vaping Product Use Associated Lung Injury |
|
| D066300 |
Electronic Nicotine Delivery Systems |
Devices or objects designed to provide NICOTINE in the form of an inhaled aerosol. |
E-Cig,E-Cigarette,Electronic Cigarette,Electronic Cigarettes,Electronic Nicotine Delivery System,E-Cigarettes,E-Cigs,Cigarette, Electronic,Cigarettes, Electronic,E Cig,E Cigarette,E Cigarettes,E Cigs |
|